Global· July 24, 2026 · 17 min read
EU vs US Biosimilars by the Numbers (2026): An EMA and FDA Purple Book Registry Comparison
By Ran Chen#Biosimilars#EMA#FDA Approval
Section
Global
Regulatory decisions, market-entry signals, and policy changes across major global agencies and launch markets.
4 articles · Last updated
Global· July 20, 2026 · 17 min read
FDA-registered device establishments by country (2026)
By Ran Chen#Supply Chain#China#BIOSECURE Act
Global· June 13, 2026 · 11 min read
What Canada approves: 13,428 drugs, generic DIN base, 89% domestic manufacturing
By Ran Chen#Health Canada#Biosimilars#Supply Chain
Global· June 8, 2026 · 11 min read
South Korea MFDS biosimilar reform 2026: what US launch teams need to know
By Ran Chen#Biosimilars#Regulatory#FDA Approval